Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Cash from Financing Activities (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Cash from Financing Activities for 16 consecutive years, with -$5.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Financing Activities fell 208.6% to -$5.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$6.9 million, a 139.89% decrease, with the full-year FY2024 number at $16.1 million, down 18.37% from a year prior.
  • Cash from Financing Activities was -$5.8 million for Q3 2025 at Xtant Medical Holdings, down from $662000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $18.1 million in Q1 2021 to a low of -$5.8 million in Q3 2025.
  • A 5-year average of $3.0 million and a median of $662000.0 in 2025 define the central range for Cash from Financing Activities.
  • Biggest YoY gain for Cash from Financing Activities was 53311.76% in 2021; the steepest drop was 1515.0% in 2021.
  • Xtant Medical Holdings' Cash from Financing Activities stood at -$55000.0 in 2021, then surged by 10307.27% to $5.6 million in 2022, then plummeted by 94.21% to $325000.0 in 2023, then crashed by 362.77% to -$854000.0 in 2024, then plummeted by 575.76% to -$5.8 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Cash from Financing Activities are -$5.8 million (Q3 2025), $662000.0 (Q2 2025), and -$919000.0 (Q1 2025).